Get started
Author

Amber D. Bowler

Observed names: A D Bowler, Amber D Bowler, Bowler, Amber Dawn
ORCID: 0000-0002-9439-2839
Observed ORCID: 0000-0002-9439-2839
OpenAlex ID: A5048867846
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
2019 · Christopher A. Eide, Matthew S. Zabriskie, et al. · Cancer Cell · 244
PDF
Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ
2019 · Markus Germann, Nadine Zangger, et al. · EMBO Molecular Medicine · 165
PDF
Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
2024 · L. Francisco Lorenzo-Martín, Tania Hübscher, et al. · Nature · 106
β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
2015 · A M Eiring, J S Khorashad, et al. · Leukemia · 44
shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance
2015 · Jamshid S. Khorashad, Anna M. Eiring, et al. · Blood · 43
Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth
2023 · Anita Bodac, Abdullah Mayet, et al. · EMBO Molecular Medicine · 35
PDF
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis
2021 · Helong Zhao, Anthony D. Pomicter, et al. · Blood · 21
Proteoglycofili are glycosaminoglycan-containing fibrillar components released by neutrophils to neutralize bacteria
2025 · Antonin C. André, Marina V. Barroso, et al. · Cell Reports · 2
Combining the Allosteric ABL1 Inhibitor Asciminib (ABL001) with Ponatinib Suppresses Emergence of and Restores Efficacy Against Highly Resistant BCR-ABL1 Compound Mutants
2019 · Christopher A. Eide, Matthew S. Zabriskie, et al. · Blood · 2
MS4A3 Improves Imatinib Response and Survival in BCR-ABL1 Primary TKI Resistance and in Blastic Transformation of Chronic Myeloid Leukemia
2015 · Anna M. Eiring, Jamshid S. Khorashad, et al. · Blood · 2
Transition of Chronic Myeloid Leukemia to Chronic Myelomonocytic Leukemia As a Tool to Observe Development of Chronic Myelomonocytic Leukemia
2015 · Jamshid S Khorashad, Srinivas K Tantravahi, et al. · Blood · 1
Unconventional T cells in urological cancers: catch them if you can
2026 · Amber D. Bowler, Sylvain Nguyen, et al. · Nature Reviews Urology
MS4A3 Promotes Differentiation in Chronic Myeloid Leukemia By Enhancing Common β Chain Cytokine Receptor Endocytosis
2021 · Helong Zhao, Anthony D. Pomicter, et al. · Blood
MS4A3: A New Player in Leukemic Stem Cell Survival in Chronic Myeloid Leukemia
2016 · Anna M. Eiring, Jamshid S. Khorashad, et al. · Blood
Works count: 15
Citation count: 665
H-index: 7
I10-index: 7
Year
Topic
Type